Literature DB >> 25894928

Sustained Delivery of Chemokine CXCL12 from Chemically Modified Silk Hydrogels.

Paige N Atterberry1, Travis J Roark1, Sean Y Severt1, Morgan L Schiller1, John M Antos1, Amanda R Murphy1.   

Abstract

A delivery platform was developed using silk-based hydrogels, and sustained delivery of the cationic chemokine CXCL12 at therapeutically relevant doses is demonstrated. Hydrogels were prepared from plain silk and silk that had been chemically modified with sulfonic acid groups. CXCL12 was mixed with the silk solution prior to gelation, resulting in 100% encapsulation efficiency, and both hydrated and lyophilized gels were compared. By attaching a fluorescein tag to CXCL12 using a site-specific sortase-mediated enzymatic ligation, release was easily quantified in a high-throughput manner using fluorescence spectroscopy. CXCL12 continually eluted from both plain and acid-modified silk hydrogels for more than 5 weeks at concentrations ranging from 10 to 160 ng per day, depending on the gel preparation method. Notably, acid-modified silk hydrogels displayed minimal burst release yet had higher long-term release rates compared to those of plain silk hydrogels. Similar release profiles were observed over a range of loading capacities, allowing dosage to be easily varied.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894928     DOI: 10.1021/acs.biomac.5b00144

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

Review 1.  Silk-based stabilization of biomacromolecules.

Authors:  Adrian B Li; Jonathan A Kluge; Nicholas A Guziewicz; Fiorenzo G Omenetto; David L Kaplan
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

Review 2.  Extended release formulations using silk proteins for controlled delivery of therapeutics.

Authors:  Burcin Yavuz; Laura Chambre; David L Kaplan
Journal:  Expert Opin Drug Deliv       Date:  2019-07-01       Impact factor: 6.648

Review 3.  Using biomaterials to modulate chemotactic signaling for central nervous system repair.

Authors:  Kassondra Hickey; Sarah E Stabenfeldt
Journal:  Biomed Mater       Date:  2018-04-27       Impact factor: 3.715

4.  Modulation of vincristine and doxorubicin binding and release from silk films.

Authors:  Jeannine M Coburn; Elim Na; David L Kaplan
Journal:  J Control Release       Date:  2015-10-21       Impact factor: 9.776

5.  Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.

Authors:  Camille Le Gall; Anna Cammarata; Lukas de Haas; Iván Ramos-Tomillero; Jorge Cuenca-Escalona; Kayleigh Schouren; Zacharias Wijfjes; Anouk M D Becker; Johanna Bödder; Yusuf Dölen; I Jolanda M de Vries; Carl G Figdor; Georgina Flórez-Grau; Martijn Verdoes
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

Review 6.  Broadening the scope of sortagging.

Authors:  Xiaolin Dai; Alexander Böker; Ulrich Glebe
Journal:  RSC Adv       Date:  2019-02-06       Impact factor: 4.036

7.  Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.

Authors:  Hsi-Chien Huang; Yun-Chieh Sung; Chung-Pin Li; Dehui Wan; Po-Han Chao; Yu-Ting Tseng; Bo-Wen Liao; Hui-Teng Cheng; Fu-Fei Hsu; Chieh-Cheng Huang; Yi-Ting Chen; Yu-Hui Liao; Hsin Tzu Hsieh; Yu-Chuan Shih; I-Ju Liu; Han-Chung Wu; Tsai-Te Lu; Jane Wang; Yunching Chen
Journal:  Gut       Date:  2021-12-17       Impact factor: 31.793

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.